Lipopolysaccharide O structure of adherent and invasive Escherichia coli regulates intestinal inflammation via complement C3
Gut dysbiosis associated with intestinal inflammation is characterized by the blooming of particular bacteria such as adherent-invasive E. coli (AIEC). However, the precise mechanisms by which AIEC impact on colitis remain largely unknown. Here we show that antibiotic-induced dysbiosis worsened chem...
Gespeichert in:
Veröffentlicht in: | PLoS pathogens 2020-10, Vol.16 (10), p.e1008928 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 10 |
container_start_page | e1008928 |
container_title | PLoS pathogens |
container_volume | 16 |
creator | Ohno, Masashi Hasegawa, Mizuho Hayashi, Atsushi Caballero-Flores, Gustavo Alteri, Christopher J Lawley, Trevor D Kamada, Nobuhiko Núñez, Gabriel Inohara, Naohiro |
description | Gut dysbiosis associated with intestinal inflammation is characterized by the blooming of particular bacteria such as adherent-invasive E. coli (AIEC). However, the precise mechanisms by which AIEC impact on colitis remain largely unknown. Here we show that antibiotic-induced dysbiosis worsened chemically-induced colitis in IL-22-deficient mice, but not in wild-type mice. The increase in intestinal inflammation was associated with the expansion of E. coli strains with genetic and functional features of AIEC. These E. coli isolates exhibited high ability to out compete related bacteria via colicins and resistance to the host complement system in vitro. Mutation of wzy, the lipopolysaccharide O polymerase gene, rendered AIEC more sensitive to the complement system and more susceptible to engulfment and killing by phagocytes while retaining its ability to outcompete related bacteria in vitro. The wzy AIEC mutant showed impaired fitness to colonize the intestine under colitic conditions, but protected mice from chemically-induced colitis. Importantly, the ability of the wzy mutant to protect from colitis was blocked by depletion of complement C3 which was associated with impaired intestinal eradication of AIEC in colitic mice. These studies link surface lipopolysaccharide O-antigen structure to the regulation of colitic activity in commensal AIEC via interactions with the complement system. |
doi_str_mv | 10.1371/journal.ppat.1008928 |
format | Article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2460983404</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A645331652</galeid><doaj_id>oai_doaj_org_article_935f58dcefaf4743a79d47e153d71f71</doaj_id><sourcerecordid>A645331652</sourcerecordid><originalsourceid>FETCH-LOGICAL-c661t-8d7bf061c4519986f1c2157708babc1e4bd7bb14707d2ada1452db9649a052953</originalsourceid><addsrcrecordid>eNqVkl2L1DAUhoso7rr6D0QLe-XFjEmTNO2NsAyrDgwu-HEdTvPRydA2NUkHF_zxZna6yw7ohQSScPKcNydvTpa9xmiJCcfvd27yA3TLcYS4xAhVdVE9yc4xY2TBCadPH-3Pshch7BCimODyeXZGCCp4UaHz7PfGjm503W0AKbfgrdL5TR6in2ScvM6dyUFttddDzGFQuR32EOxe59dBprCVWwu5dJ3NvW6nDqIOiUlztKm4tDUd9D1E64Z8f4f2Y6f7g9yKvMyeGeiCfjWvF9mPj9ffV58Xm5tP69XVZiHLEsdFpXhjUIklZbiuq9JgWWDGOaoaaCTWtElAgylHXBWgAFNWqKYuaQ2IFTUjF9nbo-7YuSBm44IoaInqilBEE7E-EsrBToze9uBvhQMr7gLOtwJ8tLLToibMsEpJbcBQTgnwWlGuMSOKY8Nx0vow3zY1vU7gED10J6KnJ4PditbtBWcclxVPApezgHc_p2TlP0qeqRZSVclol8Rkb4MUVyVlJP00KxK1_AuVhtK9lW7Qxqb4ScK7k4TERP0rtjCFINbfvv4H--WUpUdWeheC1-bBEIzEoaHvHykODS3mhk5pbx6b-ZB038HkD3D28zE</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2460983404</pqid></control><display><type>article</type><title>Lipopolysaccharide O structure of adherent and invasive Escherichia coli regulates intestinal inflammation via complement C3</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><source>Public Library of Science (PLoS)</source><creator>Ohno, Masashi ; Hasegawa, Mizuho ; Hayashi, Atsushi ; Caballero-Flores, Gustavo ; Alteri, Christopher J ; Lawley, Trevor D ; Kamada, Nobuhiko ; Núñez, Gabriel ; Inohara, Naohiro</creator><creatorcontrib>Ohno, Masashi ; Hasegawa, Mizuho ; Hayashi, Atsushi ; Caballero-Flores, Gustavo ; Alteri, Christopher J ; Lawley, Trevor D ; Kamada, Nobuhiko ; Núñez, Gabriel ; Inohara, Naohiro</creatorcontrib><description>Gut dysbiosis associated with intestinal inflammation is characterized by the blooming of particular bacteria such as adherent-invasive E. coli (AIEC). However, the precise mechanisms by which AIEC impact on colitis remain largely unknown. Here we show that antibiotic-induced dysbiosis worsened chemically-induced colitis in IL-22-deficient mice, but not in wild-type mice. The increase in intestinal inflammation was associated with the expansion of E. coli strains with genetic and functional features of AIEC. These E. coli isolates exhibited high ability to out compete related bacteria via colicins and resistance to the host complement system in vitro. Mutation of wzy, the lipopolysaccharide O polymerase gene, rendered AIEC more sensitive to the complement system and more susceptible to engulfment and killing by phagocytes while retaining its ability to outcompete related bacteria in vitro. The wzy AIEC mutant showed impaired fitness to colonize the intestine under colitic conditions, but protected mice from chemically-induced colitis. Importantly, the ability of the wzy mutant to protect from colitis was blocked by depletion of complement C3 which was associated with impaired intestinal eradication of AIEC in colitic mice. These studies link surface lipopolysaccharide O-antigen structure to the regulation of colitic activity in commensal AIEC via interactions with the complement system.</description><identifier>ISSN: 1553-7374</identifier><identifier>ISSN: 1553-7366</identifier><identifier>EISSN: 1553-7374</identifier><identifier>DOI: 10.1371/journal.ppat.1008928</identifier><identifier>PMID: 33027280</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Animals ; Antibiotics ; Antigens ; Bacteria ; Bacterial Adhesion - drug effects ; Bacterial Adhesion - physiology ; Bacterial infections ; Biology and Life Sciences ; Care and treatment ; Colicins ; Colitis ; Colon ; Complement ; Complement C3 - metabolism ; Complement component C3 ; Complement system ; Correlation analysis ; Crohn Disease - microbiology ; Cytokines ; Depletion ; Development and progression ; Dysbacteriosis ; Dysbiosis ; E coli ; Escherichia coli - drug effects ; Escherichia coli - genetics ; Escherichia coli infections ; Escherichia coli Infections - drug therapy ; Escherichia coli Infections - microbiology ; Feces ; Funding ; Health aspects ; Host-bacteria relationships ; Immune system ; Inflammation ; Inflammation - microbiology ; Inflammatory bowel disease ; Interleukin 22 ; Internal medicine ; Intestinal Mucosa - microbiology ; Intestine ; Lipopolysaccharides ; Lipopolysaccharides - chemistry ; Lipopolysaccharides - pharmacology ; Medical schools ; Medicine and Health Sciences ; Mice, Inbred C57BL ; Microbiota ; Microorganisms ; Mutants ; Mutation ; Pathology ; Phagocytes ; Rodents</subject><ispartof>PLoS pathogens, 2020-10, Vol.16 (10), p.e1008928</ispartof><rights>COPYRIGHT 2020 Public Library of Science</rights><rights>2020 Ohno et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 Ohno et al 2020 Ohno et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c661t-8d7bf061c4519986f1c2157708babc1e4bd7bb14707d2ada1452db9649a052953</citedby><cites>FETCH-LOGICAL-c661t-8d7bf061c4519986f1c2157708babc1e4bd7bb14707d2ada1452db9649a052953</cites><orcidid>0000-0002-4108-2773 ; 0000-0002-4215-9349 ; 0000-0002-1980-4178 ; 0000-0003-3505-7835 ; 0000-0002-6367-5684 ; 0000-0002-6529-2695 ; 0000-0003-4060-2383</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571687/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571687/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79343,79344</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33027280$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ohno, Masashi</creatorcontrib><creatorcontrib>Hasegawa, Mizuho</creatorcontrib><creatorcontrib>Hayashi, Atsushi</creatorcontrib><creatorcontrib>Caballero-Flores, Gustavo</creatorcontrib><creatorcontrib>Alteri, Christopher J</creatorcontrib><creatorcontrib>Lawley, Trevor D</creatorcontrib><creatorcontrib>Kamada, Nobuhiko</creatorcontrib><creatorcontrib>Núñez, Gabriel</creatorcontrib><creatorcontrib>Inohara, Naohiro</creatorcontrib><title>Lipopolysaccharide O structure of adherent and invasive Escherichia coli regulates intestinal inflammation via complement C3</title><title>PLoS pathogens</title><addtitle>PLoS Pathog</addtitle><description>Gut dysbiosis associated with intestinal inflammation is characterized by the blooming of particular bacteria such as adherent-invasive E. coli (AIEC). However, the precise mechanisms by which AIEC impact on colitis remain largely unknown. Here we show that antibiotic-induced dysbiosis worsened chemically-induced colitis in IL-22-deficient mice, but not in wild-type mice. The increase in intestinal inflammation was associated with the expansion of E. coli strains with genetic and functional features of AIEC. These E. coli isolates exhibited high ability to out compete related bacteria via colicins and resistance to the host complement system in vitro. Mutation of wzy, the lipopolysaccharide O polymerase gene, rendered AIEC more sensitive to the complement system and more susceptible to engulfment and killing by phagocytes while retaining its ability to outcompete related bacteria in vitro. The wzy AIEC mutant showed impaired fitness to colonize the intestine under colitic conditions, but protected mice from chemically-induced colitis. Importantly, the ability of the wzy mutant to protect from colitis was blocked by depletion of complement C3 which was associated with impaired intestinal eradication of AIEC in colitic mice. These studies link surface lipopolysaccharide O-antigen structure to the regulation of colitic activity in commensal AIEC via interactions with the complement system.</description><subject>Animals</subject><subject>Antibiotics</subject><subject>Antigens</subject><subject>Bacteria</subject><subject>Bacterial Adhesion - drug effects</subject><subject>Bacterial Adhesion - physiology</subject><subject>Bacterial infections</subject><subject>Biology and Life Sciences</subject><subject>Care and treatment</subject><subject>Colicins</subject><subject>Colitis</subject><subject>Colon</subject><subject>Complement</subject><subject>Complement C3 - metabolism</subject><subject>Complement component C3</subject><subject>Complement system</subject><subject>Correlation analysis</subject><subject>Crohn Disease - microbiology</subject><subject>Cytokines</subject><subject>Depletion</subject><subject>Development and progression</subject><subject>Dysbacteriosis</subject><subject>Dysbiosis</subject><subject>E coli</subject><subject>Escherichia coli - drug effects</subject><subject>Escherichia coli - genetics</subject><subject>Escherichia coli infections</subject><subject>Escherichia coli Infections - drug therapy</subject><subject>Escherichia coli Infections - microbiology</subject><subject>Feces</subject><subject>Funding</subject><subject>Health aspects</subject><subject>Host-bacteria relationships</subject><subject>Immune system</subject><subject>Inflammation</subject><subject>Inflammation - microbiology</subject><subject>Inflammatory bowel disease</subject><subject>Interleukin 22</subject><subject>Internal medicine</subject><subject>Intestinal Mucosa - microbiology</subject><subject>Intestine</subject><subject>Lipopolysaccharides</subject><subject>Lipopolysaccharides - chemistry</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>Medical schools</subject><subject>Medicine and Health Sciences</subject><subject>Mice, Inbred C57BL</subject><subject>Microbiota</subject><subject>Microorganisms</subject><subject>Mutants</subject><subject>Mutation</subject><subject>Pathology</subject><subject>Phagocytes</subject><subject>Rodents</subject><issn>1553-7374</issn><issn>1553-7366</issn><issn>1553-7374</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqVkl2L1DAUhoso7rr6D0QLe-XFjEmTNO2NsAyrDgwu-HEdTvPRydA2NUkHF_zxZna6yw7ohQSScPKcNydvTpa9xmiJCcfvd27yA3TLcYS4xAhVdVE9yc4xY2TBCadPH-3Pshch7BCimODyeXZGCCp4UaHz7PfGjm503W0AKbfgrdL5TR6in2ScvM6dyUFttddDzGFQuR32EOxe59dBprCVWwu5dJ3NvW6nDqIOiUlztKm4tDUd9D1E64Z8f4f2Y6f7g9yKvMyeGeiCfjWvF9mPj9ffV58Xm5tP69XVZiHLEsdFpXhjUIklZbiuq9JgWWDGOaoaaCTWtElAgylHXBWgAFNWqKYuaQ2IFTUjF9nbo-7YuSBm44IoaInqilBEE7E-EsrBToze9uBvhQMr7gLOtwJ8tLLToibMsEpJbcBQTgnwWlGuMSOKY8Nx0vow3zY1vU7gED10J6KnJ4PditbtBWcclxVPApezgHc_p2TlP0qeqRZSVclol8Rkb4MUVyVlJP00KxK1_AuVhtK9lW7Qxqb4ScK7k4TERP0rtjCFINbfvv4H--WUpUdWeheC1-bBEIzEoaHvHykODS3mhk5pbx6b-ZB038HkD3D28zE</recordid><startdate>20201007</startdate><enddate>20201007</enddate><creator>Ohno, Masashi</creator><creator>Hasegawa, Mizuho</creator><creator>Hayashi, Atsushi</creator><creator>Caballero-Flores, Gustavo</creator><creator>Alteri, Christopher J</creator><creator>Lawley, Trevor D</creator><creator>Kamada, Nobuhiko</creator><creator>Núñez, Gabriel</creator><creator>Inohara, Naohiro</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISN</scope><scope>ISR</scope><scope>3V.</scope><scope>7QL</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-4108-2773</orcidid><orcidid>https://orcid.org/0000-0002-4215-9349</orcidid><orcidid>https://orcid.org/0000-0002-1980-4178</orcidid><orcidid>https://orcid.org/0000-0003-3505-7835</orcidid><orcidid>https://orcid.org/0000-0002-6367-5684</orcidid><orcidid>https://orcid.org/0000-0002-6529-2695</orcidid><orcidid>https://orcid.org/0000-0003-4060-2383</orcidid></search><sort><creationdate>20201007</creationdate><title>Lipopolysaccharide O structure of adherent and invasive Escherichia coli regulates intestinal inflammation via complement C3</title><author>Ohno, Masashi ; Hasegawa, Mizuho ; Hayashi, Atsushi ; Caballero-Flores, Gustavo ; Alteri, Christopher J ; Lawley, Trevor D ; Kamada, Nobuhiko ; Núñez, Gabriel ; Inohara, Naohiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c661t-8d7bf061c4519986f1c2157708babc1e4bd7bb14707d2ada1452db9649a052953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Animals</topic><topic>Antibiotics</topic><topic>Antigens</topic><topic>Bacteria</topic><topic>Bacterial Adhesion - drug effects</topic><topic>Bacterial Adhesion - physiology</topic><topic>Bacterial infections</topic><topic>Biology and Life Sciences</topic><topic>Care and treatment</topic><topic>Colicins</topic><topic>Colitis</topic><topic>Colon</topic><topic>Complement</topic><topic>Complement C3 - metabolism</topic><topic>Complement component C3</topic><topic>Complement system</topic><topic>Correlation analysis</topic><topic>Crohn Disease - microbiology</topic><topic>Cytokines</topic><topic>Depletion</topic><topic>Development and progression</topic><topic>Dysbacteriosis</topic><topic>Dysbiosis</topic><topic>E coli</topic><topic>Escherichia coli - drug effects</topic><topic>Escherichia coli - genetics</topic><topic>Escherichia coli infections</topic><topic>Escherichia coli Infections - drug therapy</topic><topic>Escherichia coli Infections - microbiology</topic><topic>Feces</topic><topic>Funding</topic><topic>Health aspects</topic><topic>Host-bacteria relationships</topic><topic>Immune system</topic><topic>Inflammation</topic><topic>Inflammation - microbiology</topic><topic>Inflammatory bowel disease</topic><topic>Interleukin 22</topic><topic>Internal medicine</topic><topic>Intestinal Mucosa - microbiology</topic><topic>Intestine</topic><topic>Lipopolysaccharides</topic><topic>Lipopolysaccharides - chemistry</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>Medical schools</topic><topic>Medicine and Health Sciences</topic><topic>Mice, Inbred C57BL</topic><topic>Microbiota</topic><topic>Microorganisms</topic><topic>Mutants</topic><topic>Mutation</topic><topic>Pathology</topic><topic>Phagocytes</topic><topic>Rodents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ohno, Masashi</creatorcontrib><creatorcontrib>Hasegawa, Mizuho</creatorcontrib><creatorcontrib>Hayashi, Atsushi</creatorcontrib><creatorcontrib>Caballero-Flores, Gustavo</creatorcontrib><creatorcontrib>Alteri, Christopher J</creatorcontrib><creatorcontrib>Lawley, Trevor D</creatorcontrib><creatorcontrib>Kamada, Nobuhiko</creatorcontrib><creatorcontrib>Núñez, Gabriel</creatorcontrib><creatorcontrib>Inohara, Naohiro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Canada</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PLoS pathogens</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ohno, Masashi</au><au>Hasegawa, Mizuho</au><au>Hayashi, Atsushi</au><au>Caballero-Flores, Gustavo</au><au>Alteri, Christopher J</au><au>Lawley, Trevor D</au><au>Kamada, Nobuhiko</au><au>Núñez, Gabriel</au><au>Inohara, Naohiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lipopolysaccharide O structure of adherent and invasive Escherichia coli regulates intestinal inflammation via complement C3</atitle><jtitle>PLoS pathogens</jtitle><addtitle>PLoS Pathog</addtitle><date>2020-10-07</date><risdate>2020</risdate><volume>16</volume><issue>10</issue><spage>e1008928</spage><pages>e1008928-</pages><issn>1553-7374</issn><issn>1553-7366</issn><eissn>1553-7374</eissn><abstract>Gut dysbiosis associated with intestinal inflammation is characterized by the blooming of particular bacteria such as adherent-invasive E. coli (AIEC). However, the precise mechanisms by which AIEC impact on colitis remain largely unknown. Here we show that antibiotic-induced dysbiosis worsened chemically-induced colitis in IL-22-deficient mice, but not in wild-type mice. The increase in intestinal inflammation was associated with the expansion of E. coli strains with genetic and functional features of AIEC. These E. coli isolates exhibited high ability to out compete related bacteria via colicins and resistance to the host complement system in vitro. Mutation of wzy, the lipopolysaccharide O polymerase gene, rendered AIEC more sensitive to the complement system and more susceptible to engulfment and killing by phagocytes while retaining its ability to outcompete related bacteria in vitro. The wzy AIEC mutant showed impaired fitness to colonize the intestine under colitic conditions, but protected mice from chemically-induced colitis. Importantly, the ability of the wzy mutant to protect from colitis was blocked by depletion of complement C3 which was associated with impaired intestinal eradication of AIEC in colitic mice. These studies link surface lipopolysaccharide O-antigen structure to the regulation of colitic activity in commensal AIEC via interactions with the complement system.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>33027280</pmid><doi>10.1371/journal.ppat.1008928</doi><orcidid>https://orcid.org/0000-0002-4108-2773</orcidid><orcidid>https://orcid.org/0000-0002-4215-9349</orcidid><orcidid>https://orcid.org/0000-0002-1980-4178</orcidid><orcidid>https://orcid.org/0000-0003-3505-7835</orcidid><orcidid>https://orcid.org/0000-0002-6367-5684</orcidid><orcidid>https://orcid.org/0000-0002-6529-2695</orcidid><orcidid>https://orcid.org/0000-0003-4060-2383</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1553-7374 |
ispartof | PLoS pathogens, 2020-10, Vol.16 (10), p.e1008928 |
issn | 1553-7374 1553-7366 1553-7374 |
language | eng |
recordid | cdi_plos_journals_2460983404 |
source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access; Public Library of Science (PLoS) |
subjects | Animals Antibiotics Antigens Bacteria Bacterial Adhesion - drug effects Bacterial Adhesion - physiology Bacterial infections Biology and Life Sciences Care and treatment Colicins Colitis Colon Complement Complement C3 - metabolism Complement component C3 Complement system Correlation analysis Crohn Disease - microbiology Cytokines Depletion Development and progression Dysbacteriosis Dysbiosis E coli Escherichia coli - drug effects Escherichia coli - genetics Escherichia coli infections Escherichia coli Infections - drug therapy Escherichia coli Infections - microbiology Feces Funding Health aspects Host-bacteria relationships Immune system Inflammation Inflammation - microbiology Inflammatory bowel disease Interleukin 22 Internal medicine Intestinal Mucosa - microbiology Intestine Lipopolysaccharides Lipopolysaccharides - chemistry Lipopolysaccharides - pharmacology Medical schools Medicine and Health Sciences Mice, Inbred C57BL Microbiota Microorganisms Mutants Mutation Pathology Phagocytes Rodents |
title | Lipopolysaccharide O structure of adherent and invasive Escherichia coli regulates intestinal inflammation via complement C3 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T17%3A04%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lipopolysaccharide%20O%20structure%20of%20adherent%20and%20invasive%20Escherichia%20coli%20regulates%20intestinal%20inflammation%20via%20complement%20C3&rft.jtitle=PLoS%20pathogens&rft.au=Ohno,%20Masashi&rft.date=2020-10-07&rft.volume=16&rft.issue=10&rft.spage=e1008928&rft.pages=e1008928-&rft.issn=1553-7374&rft.eissn=1553-7374&rft_id=info:doi/10.1371/journal.ppat.1008928&rft_dat=%3Cgale_plos_%3EA645331652%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2460983404&rft_id=info:pmid/33027280&rft_galeid=A645331652&rft_doaj_id=oai_doaj_org_article_935f58dcefaf4743a79d47e153d71f71&rfr_iscdi=true |